de Vieira Santos Mariana Morena, da Silva Reinaldo José, da Silva Márcia Guimarães, Fecchio Denise
Departamento de Patologia, Faculdade de Medicina de Botucatu, São Paulo CEP, Brazil.
Mediators Inflamm. 2004 Feb;13(1):29-32. doi: 10.1080/09629350410001664770.
Snake venoms have been used as antineoplastic substances in several experimental models. We demonstrated in previous studies that Bothrops jararaca venom (BjV) induces inhibition of Ehrlich ascites tumor (EAT) growth accompanied by an increase of mononuclear (MN) leukocytes in all groups inoculated with EAT and/or venom. The objective of the present study was to characterize the subpopulations of MN leukocytes involved in the inhibition of EAT growth by treatment with BjV. Swiss mice were inoculated with 1.0x10(3) EAT cells by the intraperitoneal route and treated with 0.4 mg/kg of BjV by the same route (Group TV). Treatment was started 24 h after tumor cell inoculation and consisted of five intraperitoneal injections performed at 72 h intervals. After 2, 8 and 14 days, groups of animals were sacrificed and the number of B, TCD4 and TCD8 lymphocytes, macrophages and natural killer cells present in the peritoneal cavity was determined by flow cytometry. The control group consisted of animals inoculated with EAT and treated with 0.1 ml of saline under the same conditions as the experimental group (Group T). Two additional control groups consisted of animals not inoculated with EAT and treated with saline or venom. Data were analyzed statistically by the Kruskal-Wallis non-parametric test for independent samples. On the 2nd and 8th day we observed a difference between groups T and TV (group T > group TV) for all cell types, except natural killer cells, that only differed on the 2nd day. However, on the 14th day there was no difference in MN cells among groups. These data suggest that the inhibition of EAT is related to the toxic action of BjV on tumor cells and/or to the proteolytic effect of the venom on the mediators produced by the cells for growth modulation.
在多个实验模型中,蛇毒已被用作抗肿瘤物质。我们在先前的研究中证明,巴西矛头蝮蛇毒(BjV)可抑制艾氏腹水瘤(EAT)的生长,且在所有接种EAT和/或蛇毒的组中,单核(MN)白细胞数量会增加。本研究的目的是鉴定参与BjV治疗抑制EAT生长的MN白细胞亚群。通过腹腔途径给瑞士小鼠接种1.0x10(3)个EAT细胞,并通过相同途径用0.4mg/kg的BjV进行治疗(TV组)。在肿瘤细胞接种后24小时开始治疗,包括每隔72小时进行5次腹腔注射。在第2、8和14天,处死动物组,通过流式细胞术测定腹腔中存在的B细胞、TCD4和TCD8淋巴细胞、巨噬细胞和自然杀伤细胞的数量。对照组由在与实验组相同条件下接种EAT并用0.1ml生理盐水治疗的动物组成(T组)。另外两个对照组由未接种EAT并用生理盐水或蛇毒治疗的动物组成。数据通过Kruskal-Wallis独立样本非参数检验进行统计学分析。在第2天和第8天,除自然杀伤细胞仅在第2天有差异外,我们观察到T组和TV组在所有细胞类型上存在差异(T组>TV组)。然而,在第14天,各组间MN细胞无差异。这些数据表明,EAT的抑制与BjV对肿瘤细胞的毒性作用和/或毒液对细胞产生的生长调节介质的蛋白水解作用有关。